Global Rare Disease Drug Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Rare Disease Drug Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Rare Disease Drug
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Rare Disease Drug Market by Type

• 3.1 By Type
  • 3.1.1 >1
  • 3.1.2 0.65 1
  • 3.1.3 <0.1
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Rare Disease Drug Novartis AG (Company Profile, Sales Data etc.)

• 4.2 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
• 4.3 Celgene Corporation (Company Profile, Sales Data etc.)
• 4.4 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
• 4.5 Pfizer, Inc. (Company Profile, Sales Data etc.)
• 4.6 Sanofi S.A. (Company Profile, Sales Data etc.)
• 4.7 Alexion Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
• 4.8 Eli Lilly and Company (Company Profile, Sales Data etc.)
• 4.9 Novo Nordisk A/S (Company Profile, Sales Data etc.)
• 4.10 AstraZeneca (Company Profile, Sales Data etc.)
• 4.11 Eisai Co., Ltd. (Company Profile, Sales Data etc.)
• 4.12 Daiichi Sankyo Company Limited (Company Profile, Sales Data etc.)
• 4.13 Bayer AG (Company Profile, Sales Data etc.)
• 4.14 GlaxoSmithKline (Company Profile, Sales Data etc.)
• 4.15 Merck & Co., Inc. (Company Profile, Sales Data etc.)
• 4.16 Johnson & Johnson (Company Profile, Sales Data etc.)
• 4.17 Biogen, Inc. (Company Profile, Sales Data etc.)
• 4.18 Shire (Company Profile, Sales Data etc.)
• 4.19 Amgen, Inc. (Company Profile, Sales Data etc.)
• 4.20 Deciphera (Company Profile, Sales Data etc.)
• 4.21 Atara Biotherapeutics (Company Profile, Sales Data etc.)
• 4.22 ProQR (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospital Pharmacies
  • 6.1.2 Demand in Speciality Pharmacies
  • 6.1.3 Demand in Retail pharmacies
  • 6.1.4 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Rare Disease Drug

Table Application Segment of Rare Disease Drug

Table Global Rare Disease Drug Market 2013-2024, by Application, in USD Million

Table Major Company List of >1

Table Major Company List of 0.65 1

Table Major Company List of <0.1

Table Global Rare Disease Drug Market 2013-2018, by Type, in USD Million

Table Global Rare Disease Drug Market 2013-2018, by Type, in Volume

Table Global Rare Disease Drug Market Forecast 2019-2024, by Type, in USD Million

Table Global Rare Disease Drug Market Forecast 2019-2024, by Type, in Volume

Table Novartis AG Overview List

Table Rare Disease Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Company Overview List

Table Rare Disease Drug Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Rare Disease Drug Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Rare Disease Drug Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer, Inc. Overview List

Table Rare Disease Drug Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi S.A. Overview List

Table Rare Disease Drug Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Alexion Pharmaceuticals, Inc. Overview List

Table Rare Disease Drug Business Operation of Alexion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly and Company Overview List

Table Rare Disease Drug Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novo Nordisk A/S Overview List

Table Rare Disease Drug Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Rare Disease Drug Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eisai Co., Ltd. Overview List

Table Rare Disease Drug Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo Company Limited Overview List

Table Rare Disease Drug Business Operation of Daiichi Sankyo Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer AG Overview List

Table Rare Disease Drug Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Rare Disease Drug Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co., Inc. Overview List

Table Rare Disease Drug Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Rare Disease Drug Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biogen, Inc. Overview List

Table Rare Disease Drug Business Operation of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shire Overview List

Table Rare Disease Drug Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen, Inc. Overview List

Table Rare Disease Drug Business Operation of Amgen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Deciphera Overview List

Table Rare Disease Drug Business Operation of Deciphera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Atara Biotherapeutics Overview List

Table Rare Disease Drug Business Operation of Atara Biotherapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ProQR Overview List

Table Rare Disease Drug Business Operation of ProQR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Rare Disease Drug Sales Revenue 2013-2018, by Company, in USD Million

Table Global Rare Disease Drug Sales Revenue Share, by Company, in USD Million

Table Global Rare Disease Drug Sales Volume 2013-2018, by Company, in Volume

Table Global Rare Disease Drug Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Rare Disease Drug Demand Forecast 2019-2024, by Application, in USD Million

Table Rare Disease Drug Demand Forecast 2019-2024, by Application, in Volume

Table Rare Disease Drug Production 2013-2018, by Region, in USD Million

Table Rare Disease Drug Production 2013-2018, by Region, in Volume

Table Global Rare Disease Drug Market 2013-2018, by Region, in USD Million

Table Global Rare Disease Drug Market Share 2013-2018, by Region, in USD Million

Table Global Rare Disease Drug Market 2013-2018, by Region, in Volume

Table Global Rare Disease Drug Market Share 2013-2018, by Region, in Volume

Table North America Rare Disease Drug Market Size 2013-2018, by Country, in USD Million

Table North America Rare Disease Drug Market Size 2013-2018, by Country, in Volume

Table Europe Rare Disease Drug Market Size 2013-2018, by Country, in USD Million

Table Europe Rare Disease Drug Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Rare Disease Drug Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Rare Disease Drug Market Size 2013-2018, by Country, in Volume

Table South America Rare Disease Drug Market Size 2013-2018, by Country, in USD Million

Table South America Rare Disease Drug Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Rare Disease Drug Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Rare Disease Drug Market Size 2013-2018, by Country, in Volume

Table Rare Disease Drug Market Forecast 2019-2024, by Region, in USD Million

Table Rare Disease Drug Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Rare Disease Drug Market Growth 2013-2018, by Type, in USD Million

Figure Global Rare Disease Drug Market Growth 2013-2018, by Type, in Volume

Figure North America Rare Disease Drug Market Concentration, in 2018

Figure Europe Rare Disease Drug Market Market Concentration, in 2018

Figure Asia-Pacific Rare Disease Drug MMarket Concentration, in 2018

Figure South America Rare Disease Drug Market Concentration, in 2018

Figure Middle East & Africa Rare Disease Drug Market Concentration, in 2018

Figure Rare Disease Drug Demand in Hospital Pharmacies, 2013-2018, in USD Million

Figure Rare Disease Drug Demand in Hospital Pharmacies, 2013-2018, in Volume

Figure Rare Disease Drug Demand in Speciality Pharmacies, 2013-2018, in USD Million

Figure Rare Disease Drug Demand in Speciality Pharmacies, 2013-2018, in Volume

Figure Rare Disease Drug Demand in Retail pharmacies, 2013-2018, in USD Million

Figure Rare Disease Drug Demand in Retail pharmacies, 2013-2018, in Volume

Figure Rare Disease Drug Demand in Others, 2013-2018, in USD Million

Figure Rare Disease Drug Demand in Others, 2013-2018, in Volume

Figure North America Rare Disease Drug Market Size and Growth 2013-2018, in USD Million

Figure North America Rare Disease Drug Market Size and Growth 2013-2018, in Volume

Figure Europe Rare Disease Drug Market Size and Growth 2013-2018, in USD Million

Figure Europe Rare Disease Drug Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Rare Disease Drug Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Rare Disease Drug Market Size and Growth 2013-2018, in Volume

Figure South America Rare Disease Drug Market Size and Growth 2013-2018, in USD Million

Figure South America Rare Disease Drug Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Rare Disease Drug Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Rare Disease Drug Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview